MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ONCO has $19,678,868 in assets. $16,303,023 in debts.

Balance Sheets Overview

Current Ratio
7.99%
Quick Ratio
7.06%
Debt to Asset Ratio
82.85%
Assets Breakdown
    • Goodwill
    • Cash
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Warrant liabilities
    • Others

Unit: Dollar
Balance Sheets
2025-09-30
2025-06-30
Cash
836,556 283,515
Accounts receivable, net
2,552 12,156
Inventories
151,556 153,072
Prepaid expenses and other current assets
311,362 481,788
Total current assets
1,302,026 930,531
Property and equipment, net
40,388 43,809
Deferred offering costs
150,000 -
Operating right of use asset
6,155 21,400
Goodwill
18,180,299 18,123,296
Total assets
19,678,868 19,119,036
Accounts payable
1,804,163 2,581,608
Accrued expenses
476,289 894,986
Notes payable, net of debt discount of 0 and 4,966 at september 30, 2025 and december 31, 2024, respectively
160,267 8,731,571
Operating lease liability, current
6,155 21,400
Contingent warrant liabilities
53,149 -
Subscription agreement liability related party
-0
Warrant liabilities
12,815,000 53,113
Due to shareholders
-409,510
Derivative liabilities
988,000 -
Total current liabilities
16,303,023 12,692,188
Pension benefit obligation
-73,644
Total liabilities
16,303,023 12,765,832
Due from shareholders
-0
Series c redeemable preferred stock, 0.00001 par value, 10,000 shares authorized, 7 and 3,499 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively-Series CRedeemable Preferred Stock
1,724 443,443
Common stock, 0.00001 par value, 250,000,000 shares authorized at september 30, 2025 and december 31, 2024 1,560,820 and 138,422 the shares issued at september 30, 2025 and december 31, 2024, respectively 1,560,668 and 138,270 shares outstanding at september 30, 2025 and december 31, 2024, respectively
15 10
Additional paid-in capital
141,431,240 135,021,431
Treasury stock, at cost 152 shares of common stock at september 30, 2025 and december 31, 2024
625,791 625,791
Accumulated deficit
-136,884,245 -128,100,543
Accumulated other comprehensive loss
-547,098 -385,346
Total stockholders equity
3,374,121 5,909,761
Total liabilities, convertible preferred stock, and stockholders equity
19,678,868 19,119,036
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$311,362 Inventories$151,556 Accounts receivable, net$2,552 Cash$836,556 Goodwill$18,180,299 Operating right of useasset$6,155 Deferred offering costs$150,000 Property and equipment,net$40,388 Total current assets$1,302,026 Total assets$19,678,868 Total liabilities,convertible preferred...$19,678,868 Total stockholdersequity$3,374,121 Series c redeemablepreferred stock, 0.00001...$1,724 Total liabilities$16,303,023 Accumulated othercomprehensive loss-$547,098 Accumulated deficit-$136,884,245 Treasury stock, at cost152 shares of common...$625,791 Additional paid-in capital$141,431,240 Total currentliabilities$16,303,023 Common stock, 0.00001par value,...$15 Derivative liabilities$988,000 Warrant liabilities$12,815,000 Contingent warrantliabilities$53,149 Operating leaseliability, current$6,155 Notes payable, net ofdebt discount of 0 and...$160,267 Accrued expenses$476,289 Accounts payable$1,804,163

Onconetix, Inc. (ONCO)

Onconetix, Inc. (ONCO)